References
- Oscier DG, Gardiner AC, Mould SJ, . Multivariate analysis of prognostic factors in CLL: clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors. Blood 2002;100:1177–1184.
- Shim GJ, Kis LL, Warner M, . Autoimmune glomerulonephritis with spontaneous formation of splenic germinal centers in mice lacking the estrogen receptor alpha gene. Proc Natl Acad Sci USA 2004;101:1720–1724.
- Shim GJ, Wang L, Andersson S, . Disruption of the estrogen receptor beta gene in mice causes myeloproliferative disease resembling chronic myeloid leukemia with lymphoid blast crisis. Proc Natl Acad Sci USA 2003;100:6694–6699.
- Nilsson S, Makela S, Treuter E, . Mechanisms of estrogen action. Physiol Rev 2001;81:1535–1565.
- Matthews J, Gustafsson JA. Estrogen signaling: a subtle balance between ER alpha and ER beta. Mol Interv 2003;3:281–292.
- Zhao C, Dahlman-Wright K, Gustafsson JA. Estrogen receptor beta: an overview and update. Nucl Recept Signal 2008;6:e003.
- Ogawa S, Inoue S, Watanabe T, . Molecular cloning and characterization of human estrogen receptor betacx: a potential inhibitor ofestrogen action in human. Nucleic Acids Res 1998;26:3505–3512.
- Zhao C, Matthews J, Tujague M, . Estrogen receptor beta2 negatively regulates the transactivation of estrogen receptor alpha in human breast cancer cells. Cancer Res 2007;67:3955–3962.
- Esslimani-Sahla M, Kramar A, Simony-Lafontaine J, . Increased estrogen receptor betacx expression during mammary carcinogenesis. Clin Cancer Res 2005;11:3170–3174.
- Saji S, Omoto Y, Shimizu C, . Expression of estrogen receptor (ER) (beta)cx protein in ER(alpha)-positive breast cancer: specific correlation with progesterone receptor. Cancer Res 2002;62:4849–4853.
- Shim GJ, Gherman D, Kim HJ, . Differential expression of oestrogen receptors in human secondary lymphoid tissues. J Pathol 2006;208:408–414.
- Phiel KL, Henderson RA, Adelman SJ, . Differential estrogen receptor gene expression in human peripheral blood mononuclear cell populations. Immunol Lett 2005;97:107–113.
- Rosen ST, Maciorowski Z, Wittlin F, . Estrogen receptor analysis in chronic lymphocytic leukemia. Blood 1983;62:996–999.
- Zaniboni A, Di Lorenzo D, Simoncini E, . Estrogen and progesterone receptor guideline for tamoxifen therapy in chronic lymphocytic leukemia: a pilot study. Acta Haematol 1986;75:92–95.
- Melo N, Hobday C, Dowsett M, . Oestrogen receptor (ER) analysis in B-cell chronic lymphocytic leukemia: correlation of biochemical and immunocytochemical methods. Leuk Res 1990;14:949–952.
- Simonsson B, Terenius L, Nilsson K. Glucocorticoid receptors, clinical characteristics, and implications for prognosis in chronic lymphocytic leukemia. Cancer 1982;49:2493–2496.
- Kuiper GG, Enmark E, Pelto-Huikko M, . Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 1996;93:5925–5930.
- Hallek M, Cheson BD, Catovsky D, . Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood 2008;111:5446–5456.
- Saji S, Jensen EV, Nilsson S, . Estrogen receptors alpha and beta in the rodent mammary gland. Proc Natl Acad Sci USA 2000;97:337–342.
- Shim GJ, Warner M, Kim HJ, . Aromatase-deficient mice spontaneously develop a lymphoproliferative autoimmune disease resembling Sjogren's syndrome. Proc Natl Acad Sci USA 2004;101:12628–12633.
- Girault I, Andrieu C, Tozlu S, . Altered expression pattern of alternatively spliced estrogen receptor beta transcripts in breast carcinoma. Cancer Lett 2004;215:101–112.
- Stygar D, Westlund P, Eriksson H, . Identification of wild type and variants of oestrogen receptors in polymorphonuclear and mononuclear leucocytes. Clin Endocrinol (Oxf) 2006;64:74–81.
- Xu Q, Lee C. Discovery of novel splice forms and functional analysis of cancer-specific alternative splicing in human expressed sequences. Nucleic Acids Res 2003;31:5635–5643.
- Strom A, Hartman J, Foster JS, . Estrogen receptor beta inhibits 17beta-estradiol-stimulated proliferation of the breast cancer cell line T47D. Proc Natl Acad Sci USA 2004;101:1566–1571.
- Hartman J, Lindberg K, Morani A, . Estrogen receptor beta inhibits angiogenesis and growth of T47D breast cancer xenografts. Cancer Res 2006;66:11207–11213.
- Liu MM, Albanese C, Anderson CM, . Opposing action of estrogen receptors alpha and beta on cyclin D1 gene expression. J Biol Chem 2002;277:24353–24360.
- Burger JA, Tsukada N, Burger M, . Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1. Blood 2000;96:2655–2663.
- Kuiper GG, Lemmen JG, Carlsson B, . Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 1998;139:4252–4263.
- Mansour A, Chang VT, Srinivas S, . Correlation of ZAP-70 expression in B cell leukemias to the ex vivo response to a combination of fludarabine/genistein. Cancer Immunol Immunother 2007;56:501–514.
- McCall JL, Burich RA, Mack PC. GCP, a genistein-rich compound, inhibits proliferation and induces apoptosis in lymphoma cell lines. Leuk Res 2010;34:69–76.
- Yakimchuk K, Iravani M, Hasni MS, . Effect of ligand-activated estrogen receptor β on lymphoma growth in vitro and in vivo. Leukemia. 2011;25:1103–1110.